MedTrace Logo

Vitamin D During In Vitro Fertilisation (IVF) - A Prospective Randomized Trial

NCT01019785 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2009-11-25

No results posted yet for this study

Summary

During IVF treatment women will be randomized into supplementation with a high or a low dose of Vitamin D Main outcome Laboratory pregnancy, live pregnancy at 12 weeks, Baby take home rate, OHSS Secondary outcome: 1. Pregnancy complications (pregnancy hypertension, SGA, Diabetes) 2.Thrombin generation

Conditions

  • Pregnancy Complication

Interventions

DIETARY_SUPPLEMENT

Ergocalciferol

100 000 U drops is given once

DIETARY_SUPPLEMENT

Ergocalciferol

500 U drops given once

Sponsors & Collaborators

  • Karolinska University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2011-11-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01019785 on ClinicalTrials.gov